Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial ....

CITURGIA BIOCHEMICALS LIMITED Regd. Office: Office No. 427, A-Wing, 4th Floor Floor, Mainframe Premises C.S.L Royal Palms, Aareymilk Colony, Goregaon East, Mumbai-400065 Maharashtra, CIN: L24100MH1974PLC017773 Website: www.citurgiabiochemicals.com; E-mail id: citurgia_bio@yahoo.com To, Date: 04th August, 2026 BSE Limited PhirozeJeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Code : 506373 Scrip Id : CITURGIA Dear Sir/Madam, Sub: Intimation of Board Meeting to Consider and Approve Unaudited Financial Results (Standalone) for the quarter ended June 30, 2026. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”), this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 12th August, 2026, inter-alia to: 1. Consider and approve Unaudited financial results for the quarter ended on 30th June, 2026 2. To consider any other business as per the agenda. As informed earlier, Trading Window for trading in the Company’s equity shares was closed for the Company's Directors, Officers, designated employees and other connected persons of the Company from Wednesday, 01st July, 2026 and shall open 48 hours after the aforesaid financial results are declared to Stock Exchanges. This is for your kind information and records please. Thanks & Regards